Letter to the Editor: On prescription drug price reform
I’m writing about prescription drug price reform and why this issue should be top priority for voters in the Presidential campaign. While the nation is appropriately focused on the
Coronavirus pandemic, we can’t forget about other health care priorities that continue to impact millions of Americans.
Like nearly 1 million Americans, I have been diagnosed with Multiple Sclerosis, a chronic and debilitating medical condition. I depend on reliable access to prescription drug therapies to maintain a good quality of life.
Unfortunately, over the past several years, the cost of the medications I need have increased year after year. The National Multiple Sclerosis Society reports the cost of drug therapies to treat MS doubled between 2011 and 2017. The median cost for brand drug therapies to treat MS is $91,000 each year.
As the price of prescription medications continue to increase, it makes it harder for Americans to access the medications they need. Politicians in Washington have talked a long time about the need to address this problem but the burden on me keeps going up.
As candidates for President and other elected offices ask the people for their votes, I urge you to consider their position on prescription drug price reform. Voters should demand leadership and results from their elected leaders on an issue that affects the lives of many.
Elections matter and, together, voters who care about this issue can make a difference.